Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 2 C, Sup. Fig. 2 A C
Neilson KM et al. (2020)
|
Xla Wt + mcrs1
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 2 C N P
Neilson KM et al. (2020)
|
Xla Wt + mcrs1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 6 B col 1
Neilson KM et al. (2020)
|
Xla Wt + six1 MO
NF13-18 (in situ hybridization)
|
|
|
|
Fig. 8 B
Sullivan CH et al. (2019)
|
Xla Wt + irx1
NF 16-NF 18 (in situ hybridization)
|
|
|
|
fig.6.c
Gaur S et al. (2016)
|
Xla Wt + foxd4l1.1
NF11.5 (in situ hybridization)
|
|
|
|
fig.6.c
Gaur S et al. (2016)
|
Xla Wt + Hsa.foxd4
NF11.5 (in situ hybridization)
|
|
|
|
fig.6.c
Gaur S et al. (2016)
|
Xla Wt + Hsa.foxd4l1.1
NF11.5 (in situ hybridization)
|
|
|
|
fig.5.c
Wang C et al. (2015)
|
Xla Wt + ets1
NF17 (in situ hybridization)
|
|
|
|
fig.4.b
Pieper M et al. (2012)
|
Xla Wt + dlx3
NF16 (in situ hybridization)
|
|
|
|
fig.S3.b
Pieper M et al. (2012)
|
Xla Wt + dlx3del-EnR
NF16 (in situ hybridization)
|
|
|